Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07375225
Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy
Sponsor: Federico II University
View on ClinicalTrials.gov
Summary
Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.
Official title: Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy - The ALINET Registry
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
1500
Start Date
2024-12-01
Completion Date
2027-12-01
Last Updated
2026-01-29
Healthy Volunteers
No
Conditions
Interventions
DRUG
Praluent (Alirocumab)
Alirocumab 300 mg injection
Locations (1)
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Napoli, Italy